TARS logo

Tarsus Pharmaceuticals (TARS) Accounts payable

annual accounts payable:

$27.74M+$9.97M(+56.08%)
December 31, 2024

Summary

  • As of today (May 23, 2025), TARS annual accounts payable is $27.74 million, with the most recent change of +$9.97 million (+56.08%) on December 31, 2024.
  • During the last 3 years, TARS annual accounts payable has risen by +$24.88 million (+871.25%).
  • TARS annual accounts payable is now at all-time high.

Performance

TARS Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly accounts payable:

$28.38M+$644.00K(+2.32%)
March 31, 2025

Summary

  • As of today (May 23, 2025), TARS quarterly accounts payable is $28.38 million, with the most recent change of +$644.00 thousand (+2.32%) on March 31, 2025.
  • Over the past year, TARS quarterly accounts payable has increased by +$9.24 million (+48.28%).
  • TARS quarterly accounts payable is now at all-time high.

Performance

TARS quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

TARS Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+56.1%+48.3%
3 y3 years+871.3%+604.6%
5 y5 years+5983.1%-

TARS Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+871.3%at high+604.6%
5 y5-yearat high+5983.1%at high+1898.8%
alltimeall timeat high>+9999.0%at high+6124.3%

TARS Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$28.38M(+2.3%)
Dec 2024
$27.74M(+56.1%)
$27.74M(+3.4%)
Sep 2024
-
$26.82M(+0.6%)
Jun 2024
-
$26.65M(+39.2%)
Mar 2024
-
$19.14M(+7.7%)
Dec 2023
$17.77M(+223.2%)
$17.77M(+71.2%)
Sep 2023
-
$10.38M(+27.0%)
Jun 2023
-
$8.17M(+8.0%)
Mar 2023
-
$7.57M(+37.6%)
Dec 2022
$5.50M
$5.50M(-1.7%)
Sep 2022
-
$5.59M(+36.6%)
DateAnnualQuarterly
Jun 2022
-
$4.09M(+1.6%)
Mar 2022
-
$4.03M(+41.0%)
Dec 2021
$2.86M(+27.7%)
$2.86M(+42.1%)
Sep 2021
-
$2.01M(-39.1%)
Jun 2021
-
$3.30M(-33.9%)
Mar 2021
-
$5.00M(+123.4%)
Dec 2020
$2.24M(+390.6%)
$2.24M(-52.5%)
Sep 2020
-
$4.71M(+231.4%)
Jun 2020
-
$1.42M(+211.4%)
Dec 2019
$456.00K(+160.6%)
$456.00K
Dec 2018
$175.00K
-

FAQ

  • What is Tarsus Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual accounts payable year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly accounts payable year-on-year change?

What is Tarsus Pharmaceuticals annual accounts payable?

The current annual accounts payable of TARS is $27.74M

What is the all time high annual accounts payable for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual accounts payable is $27.74M

What is Tarsus Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, TARS annual accounts payable has changed by +$9.97M (+56.08%)

What is Tarsus Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of TARS is $28.38M

What is the all time high quarterly accounts payable for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly accounts payable is $28.38M

What is Tarsus Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, TARS quarterly accounts payable has changed by +$9.24M (+48.28%)
On this page